Brazilian Nonproprietary Name
Brazilian Nonproprietary Name (BNN) is a system of nomenclature for pharmaceutical drugs used in Brazil. It is designed to provide a standardized, clear, and precise system for the identification of medication. The BNN is similar to the International Nonproprietary Name (INN) system used globally, but it has specific adaptations to meet the needs of the Brazilian healthcare system.
Overview[edit | edit source]
The BNN system is managed by the Brazilian Health Regulatory Agency (ANVISA), which is responsible for the regulation and control of pharmaceuticals in Brazil. The agency assigns a unique BNN to each active ingredient of a drug. This name is independent of the brand name under which the drug is sold, allowing for clear communication and precise identification of drugs across different healthcare providers and patients.
Purpose[edit | edit source]
The main purpose of the BNN system is to provide a unique, standardized name for each pharmaceutical substance, regardless of the brand under which it is sold. This helps to avoid confusion and errors in medication use, as the same substance can be sold under different brand names. The BNN system also facilitates the exchange of information among healthcare professionals and patients, as well as the comparison of drugs from different manufacturers.
Naming Process[edit | edit source]
The process of assigning a BNN begins with a proposal from the manufacturer or importer of the drug. The proposal is then reviewed by ANVISA, which considers factors such as the drug's chemical structure, mechanism of action, and therapeutic use. If approved, the proposed name becomes the official BNN for that substance.
Comparison with Other Systems[edit | edit source]
While the BNN system is similar to the INN system, there are some differences. For example, the BNN system includes specific adaptations to meet the needs of the Brazilian healthcare system, such as the inclusion of certain indigenous plants used in traditional medicine. Additionally, while the INN system is managed by the World Health Organization, the BNN system is managed by ANVISA.
See Also[edit | edit source]
- International Nonproprietary Name
- United States Adopted Name
- British Approved Name
- Japanese Accepted Name
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
